TD Cowen Maintains Buy on Surgery Partners, Raises Price Target to $19

Benzinga · 3d ago
TD Cowen analyst Ryan Langston maintains Surgery Partners (NASDAQ:SGRY) with a Buy and raises the price target from $17 to $19.